Literature DB >> 33972931

Political neglect of COVID-19 and the public health consequences in Brazil: The high costs of science denial.

Monica Malta1,2,3, Mario Vianna Vettore4, Cosme Marcelo Furtado Passos da Silva5, Angelica Baptista Silva6, Steffanie A Strathdee7.   

Abstract

Entities:  

Year:  2021        PMID: 33972931      PMCID: PMC8099674          DOI: 10.1016/j.eclinm.2021.100878

Source DB:  PubMed          Journal:  EClinicalMedicine        ISSN: 2589-5370


× No keyword cloud information.
Brazil represents a tragic example of how lack of appropriate policies and pandemic denial impact public health. The country of 212 million inhabitants (3% of the world population) recorded around 1/3 of all daily COVID-19 deaths worldwide in late March 2021 [1]. Brazil's brutal surge in COVID-19 deaths in the first months of 2021 has been climbing steadily, reaching over 4000 fatalities/day in early April, as a consequence of the widespread of the new variants overwhelming hospitals. In spite of the alarming scenario, the federal government is not yet adopting evidence-based and reliable public health measures, such as use of masks and social distancing. Brazil's public health system provides healthcare for 78% of the population. Its free, publicly funded national vaccination program has an excellent track record: 96% of the population is vaccinated against TB, diphtheria, polio and hepatitis [2]. However the country is struggling with a slow COVID-19 vaccine rollout, pushing the country's healthcare system to the brink. The lack of federal government leadership is leading state governors to negotiate and purchase COVID-19 vaccines within a consortium of governors, facing several delays and difficulties. Brazil's president, Jair Bolsonaro, first downplayed the thread of COVID-19 and later embraced herd immunity as an effective strategy. The country never adopted a national lockdown, even in hardest hit cities such as Manaus [3]. Brazil's capital declared a 24-hour lockdown in February 2021, while larger cities such as Sao Paulo and Rio de Janeiro adopted nightly curfews and nonessential business closures around March 2021. However, after a 10-day lock down adopted by Araraquara, a middle-sized city in Southeast region, COVID-19 cases reduced by 43%.[4]. The legacy of Brazil's failed approach to tackle the pandemic has led to soaring COVID-19 incidence and mortality rates, mostly driven by the highly contagious P.1 variant [5]. If Brazil continues to allow SARS-CoV2 to circulate freely, it could create the ideal breeding ground for new and even more deadly variants [6]. Over 17 million Brazilians live in slums (favelas), highly density areas lacking adequate access to clean water and sanitation, where social distancing is impossible and pre-existing conditions are highly prevalent. However, the population had extremely low access to COVID-19 testing and there has been no intervention to address their increased risks [7]. Even with cases and deaths skyrocketing, Mr. Bolsonaro considered the lockdown proposals absurd and unnecessary. According to Brazil's president, the population should “recognize that death is inevitability” and Brazilians should stop being “sissies” [8]. Mr. Bolsonaro even threatened to cut off federal emergency pandemic budget to states adopting partial lockdowns. During the pandemic, President Bolsonaro appointed four health ministers [9] - another clear example of the turmoil faced by the country. The first two health ministers were fired due to disagreements with the president about strategies to control the pandemic, including the president's support for anti-malarial drugs as a ‘preventive kit’ to avoid COVID-19 infection and decrees allowing non-essential services to remain open. The third health minister, Mr. Pazuello was an active-duty army general without medical or public health training. Mr. Pazuello followed president Bolsonaro support to amplify the use of anti-malarial drugs, down-played the need of social distancing and failed to respond calls from states running out of oxygen, doing the bare minimum to procure COVID-19 vaccines. In October 2020, Mr. Pazuello announced the purchase of 46 million doses of COVID-19 vaccine produced by Chinese pharmaceutical company Sinovac, but president Bolsonaro rejected the decision. The country's immunization program has been widely criticized for being late and chaotic. More recently, several private companies started offering ‘early COVID treatment’ to their employees including hydroxychloroquine, ivermectin, azithromycin, vitamin D, and vitamin C (among others), referred to as the “COVID-kit”. Many companies are requiring employees to adopt those “prophylactic treatments”, despite evidence of the effectiveness of such drugs and the potential for their misuse to contribute to antimicrobial resistance. Employees who take the “COVID-kit” frequently report a sense of ‘invincibility’ and being ‘immune’, aspects that might influence the adoption of unsafe habits such as inadequate social distancing and inconsistent mask use [10]. The burgeoning COVID-19 epidemic in Brazil was an avoidable tragedy. A national task force involving the federal government, states and municipalities is of paramount importance to enhance physical measures and scale-up vaccination to mitigate the impact of COVID-19 in Brazil and mitigate the spread of variants of concern to other countries.

Author's contributions

MM drafted the original comment and coordinated subsequent edits and revisions. MVV,CMFPS, ABS and SAS participated in drafting the comment and its finalization. All authors have read and approved the final comment.

Declaration of Competing Interest

Dr. Monica Malta acknowledges funding from R21 MH119496 (PI) and R01 MH119101 (consultant). Dr. Steffanie Strathdee acknowledges funding from R01 DA049644.
  11 in total

Review 1.  An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic.

Authors:  Julian W Tang; Miguela A Caniza; Mike Dinn; Dominic E Dwyer; Jean-Michel Heraud; Lance C Jennings; Jen Kok; Kin On Kwok; Yuguo Li; Tze Ping Loh; Linsey C Marr; Eva Megumi Nara; Nelun Perera; Reiko Saito; Carlos Santillan-Salas; Sheena Sullivan; Matt Warner; Aripuanã Watanabe; Sabeen Khurshid Zaidi
Journal:  Interface Focus       Date:  2022-02-11       Impact factor: 3.906

2.  Impacts of a delayed and slow-paced vaccination on cases and deaths during the COVID-19 pandemic: a modelling study.

Authors:  Gustavo Barbosa Libotte; Lucas Dos Anjos; Regina Célia Cerqueira de Almeida; Sandra Mara Cardoso Malta; Roberto de Andrade Medronho
Journal:  J R Soc Interface       Date:  2022-05-25       Impact factor: 4.293

3.  From response to transformation: how countries can strengthen national pandemic preparedness and response systems.

Authors:  Victoria Haldane; Anne-Sophie Jung; Rachel Neill; Sudhvir Singh; Shishi Wu; Margaret Jamieson; Monica Verma; Melisa Tan; Chuan De Foo; Salma M Abdalla; Pami Shrestha; Alvin Qijia Chua; Anders Nordström; Helena Legido-Quigley
Journal:  BMJ       Date:  2021-11-28

4.  Preventing the Next Pandemic: The Case for Investing in Circulatory Health - A Global Coalition for Circulatory Health Position Paper.

Authors:  Leslie Rae Ferat; Ryan Forrest; Kawaldip Sehmi; Raul D Santos; David Stewart; Andrew J M Boulton; Beatriz Yáñez Jiménez; Phil Riley; Dylan Burger; Erika S W Jones; Maciej Tomaszewski; Maria Rita Milanese; Paul Laffin; Vivekanand Jha; Bettina Borisch; Michael Moore; Fausto J Pinto; Daniel Piñeiro; Jean-Luc Eiselé; Daniel T Lackland; Paul K Whelton; Xin-Hua Zhang; Anna Stavdal; Donald Li; Richard Hobbs; Jeyaraj Durai Pandian; Michael Brainin; Valery Feigin
Journal:  Glob Heart       Date:  2021-10-12

5.  Involvement of political and socio-economic factors in the spatial and temporal dynamics of COVID-19 outcomes in Brazil: A population-based study.

Authors:  Diego Ricardo Xavier; Eliane Lima E Silva; Flávio Alves Lara; Gabriel R R E Silva; Marcus F Oliveira; Helen Gurgel; Christovam Barcellos
Journal:  Lancet Reg Health Am       Date:  2022-03-14

6.  Are leading urban centers predisposed to global risks- A analysis of the global south from COVID-19 perspective.

Authors:  Himanshu Shekhar; Malvika Rautela; Mehmooda Maqsood; Ricardo Paris; Rafael Maximiliano Flores de León; María Fernanda Romero-Aguirre; Marygrace Balinos; Mariana Estrada Velázquez; Gita Salehi Amri; Tamanna Rahman; Augustine Yaw Asuah; Jilan Hosni; Md Shahinoor Rahman
Journal:  Habitat Int       Date:  2022-01-31

7.  Knowledge of COVID-19 among Brazilian health care professionals and associated factors.

Authors:  João Marcos Bernardes; Daniela Mendes Dos Santos Magalhães; Melissa Spröesser Alonso; Juan Gómez-Salgado; Carlos Ruiz-Frutos; Adolfo Romero; Adriano Días
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

8.  How has the sustainability of countries changed after COVID-19? Evidence from the pandemics' first year.

Authors:  B F Giannetti; T Fonseca; F Agostinho; L C T Santos; C M V B Almeida
Journal:  Sci Total Environ       Date:  2022-09-15       Impact factor: 10.753

9.  Misinformation on social networks during the novel coronavirus pandemic: a quali-quantitative case study of Brazil.

Authors:  Priscila Biancovilli; Lilla Makszin; Claudia Jurberg
Journal:  BMC Public Health       Date:  2021-06-23       Impact factor: 3.295

10.  A year of living distantly: global trends in the use of stay-at-home orders over the first 12 months of the COVID-19 pandemic.

Authors:  Toby Phillips; Yuxi Zhang; Anna Petherick
Journal:  Interface Focus       Date:  2021-10-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.